UNIVERSAL APPROACH TO THE PREVENTION OF THE SYNDROME OF PATHOLOGICAL PREGNANCY


Cite item

Full Text

Abstract

Aim - the purpose of the study is the development of a method for prevention of pathological pregnancy syndrome from the perspective of integral genesis, determined by morphological and functional abnormalities in the fetoplacental system, assessing the effectiveness of methodological standards of evidence-based medicine. Materials and methods. Prospective study of 435 women with high risk of decompensation of placental insufficiency was conducted. Depending on the method of prevention of gestational complications 4 groups were formed: 1st group included 145 pregnant women, who were prescribed dydrogesterone on the 6-20 weeks of gestation, and starting with the 21st week - highly-purified diosmin 600 mg as vasoprotective; in the 2nd group 118 women received a course of preventive treatment with low doses of acetylsalicylic acid; 3rd group included 102 patients who underwent a course of preventive monotherapy with magnesium; 4th group comprised 70 pregnant women who refused preventive treatment. A control group encompassed 30 healthy pregnant women. Dynamic survey included definition of markers of endothelial and hemostasiological dysfunction, vascular-platelet dysfunction elements, apoptosis, inflammatory response, total reactive capacity of the organism, magnesium and carbon dioxide concentrations; a hystostereometric study of placenta was conducted. Standards of evidence-based medicine were applied for the objectification of the effectiveness of the developed method. Results. Method of preventing great obstetric syndromes by successive appointment of progestogen dydrogesterone on the early stage of pregnancy followed by vasoprotective diosmin 600 mg in the 2nd half of pregnancy showed high efficiency (NNT 1.4 (95% CI 1.1 -1.7); OSH 5.3 (95% CI 4.7 -5.8), namely reducing pre-eclampsia by 93%, placental insufficiency with intrauterine growth restriction and/or chronic fetal hypoxia - 95%, preterm birth - 86%, and no premature abruption of normally situated placenta, severe forms of pre-eclampsia and placental insufficiency. Higher clinical effectiveness of the proposed method of prophylaxis of pathological pregnancy syndrome, compared to the use of low-dose acetylsalicylic acid and preparation of magnesium, can be explained by the normalizing effect of dydrogesterone and highly-purified diosmin 600 mg on the immune and biochemical homeostasis, apoptosis and angiogenesis, activation of endothelial and hemostasiological system, adaptive compensatory reactions in the placenta. Conclusion. The method of choice for the prevention of pathological pregnancy syndrome at high risk of fetoplacental system decompensation is the application of progestogen dydrogesterone and vasoprotective diosmin according to the developed method. The study revealed the potential of targeted selection of preventive methods depending on special needs of pregnant women.

About the authors

IS S Lipatov

Samara State Medical University

Email: i.lipatoff2012@yandex.ru
PhD, Professor, professor of the Department of obstetrics and gynecology №1, Samara State Medical University.

YuV V Tezikov

Samara State Medical University

Email: yra.75@inbox.ru
PhD, associate professor, head of the Department of obstetrics and gynecology №1, Samara State Medical University 155 Tachkentskaya st Samara, Russia, 443095

NV V Martynova

Samara State Medical University

Email: nadya-martynova@yandex.ru
clinical resident of the Department of obstetrics and gynecology №1, Samara State Medical University.

LK K Mingalieva

Samara State Medical University

linical intern of the Department of obstetrics and gynecology №1, Samara State Medical University

LYu Yu Gogel

Samara State Medical University

Email: golliudmila@yandex.ru
PhD, teaching assistant of the Department of obstetrics and gynecology №1, Samara State Medical University.

TS S Belokoneva

Samara State Medical University

Email: belokonevats@mail.ru
PhD, teaching assistant of the Department of obstetrics and gynecology №1, Samara State Medical University

OB B Kalinkina

Samara State Medical University

Email: maiorof@mail.ru
PhD, associate professor, professor of the Department of obstetrics and gynecology №1, Samara State Medical University

EV V Zhernakova

Samara State Medical University

Email: l9276500625@yandex.ru
senior research technician of the Department of obstetrics and gynecology №1, Samara State Medical University

RR R Yusupova

Samara State Medical University

References

  1. Стрижаков А.Н., Липатов И.С., Тезиков Ю.В. Плацентарная недостаточность: Патогенез. Прогнозирование. Диагностика. Профилактика. Акушерская тактика. Самара: ОФОРТ. 2014
  2. Савельева Г.М., Панина О.Б., Курцер М.А., Гнетецкая В.А., Бугеренко Е.Ю., Коновалова О.В. Пренатальный период: физиология и патология. Российский вестник акушера-гинеколога. 2010 (2): 61-65
  3. Mor G, Gardenas I, Abrahams V, Guller S. Inflammation and pregnancy: the role of the immune system at the implantation site. Annals of the New York Academy of Sciences. 2011; 1221(1): 80-87. doi: 10.1111/j.1749-6632.2010.05938.x
  4. Сидорова И.С., Никитина Н.А. Предиктивный, превентивный подход к ведению беременных группы риска развития преэклампсии. Российский вестник акушера-гинеколога. 2014; 14(5): 44-49
  5. Липатов И.С., Тезиков Ю.В., Тютюнник В.Л., Кан Н.Е., Протасов А.Д., Мартынова Н.В., Жернакова Е.В., Букреева А.А. Профилактика потерь беременности ранних сроков. Акушерство и гинекология. 2017 (1): 24-33
  6. Сухих Г.Т., Красный А.М., Кан Н.Е., Майорова Т.Д., Тютюнник В.Л., Ховхаева ПА. и др. Апоптоз и экспрессия ферментов антиоксидантной защиты в плаценте при преэклампсии. Акушерство и гинекология. 2015(3): 11-15
  7. Brosens I, Pijnenborg R, Vercruysse L, Romero R. The «Great Obstetrical Syndromes» are associated with disorders of deep placentation. Am J Obstet. Gynec. 2011; 204(3): 193-201
  8. Kwak-Kim J, Park JC, Ahn HK, Kim JW, Gilman-Sachs A. Immunological modes of pregnancy loss. American Journal of Reproductive Immunology. 2010; 63(6): 611-623. doi: 10.1111/ j.1600-0897.2010.00847.x
  9. Тезиков Ю.В., Липатов И.С., Фролова НА., Кутузова О.А., Рябова С.А., Приходько А.В., Ковязина И.О., Табельская Т.В. Способ профилактики синдрома патологической беременности: патент РФ на изобретение №2575789, приоритет от 22.01.2015. Бюл. Изобретения. Полезные модели. Archive4/PAT/2016FULL/2016/02/20/ DOC/RUNWC1/000/000/002/575/789/DOCUMENT.PDF (дата обращения: 20.04.2017)
  10. Walsh J.M., McGowan C.A, Byrne J.A, Rath A. et al., The association between TNF-a and insulin resistance in englycemic women. Citokine. 2013; 64(1): 208-212. doi: 10.1016/j.cyto. 2013.07.001
  11. Стрижаков А.Н., Липатов И.С., Тезиков Ю.В., Шарыпова М.А. Стандартизация диагностики и клиническая классификация хронической плацентарной недостаточности. Вопросы гинекологии, акушерства и перинатологии. 2014; 13(3): 5-12
  12. Тезиков Ю.В., Липатов И.С., Агаркова И.А. Факторы риска декомпенсации плацентарной недостаточности. Казанский медицинский журнал. 2011; XCII(3): 372-376
  13. Тезиков Ю.В., Липатов И.С. Результаты применения карбогенотерапии для профилактики плацентарной недостаточности. Российский вестникакушера-гинеколога. 2011; 11(5): 71-78
  14. Игнатко И.В., Гониянц ГГ. Профилактика репродуктивных потерь и плацентарной недостаточности у беременных с ранним токсикозом. Вопросы гинекологии, акушерства и перинатологии. 2008; 7 (6): 25-32
  15. Котельников Г.П., Шпигель А.С. Доказательная медицина. Научно- обоснованная медицинская практика. М: ГЭОТАР-Медиа 2012: 210-222

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2017 Lipatov I.S., Tezikov Y.V., Martynova N.V., Mingalieva L.K., Gogel L.Y., Belokoneva T.S., Kalinkina O.B., Zhernakova E.V., Yusupova R.R.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).